Effects of the Couplet Care in Neonatal Intensive Care Unit
Launched by TURKU UNIVERSITY HOSPITAL · Dec 8, 2022
Trial Information
Current as of July 04, 2025
Unknown status
Keywords
ClinConnect Summary
Background: It is essential to keep newborn infants and their parents together for the well-being of both. However, the families whose infants need admission to the neonatal intensive care unit (NICU) are often separated. One of the solutions to reduce parent-infant separation is couplet care, where both mother and newborn infant receive their postpartum care in the same hospital room, even if the infant needs intensive care. However, currently only a few NICUs practice couplet care, and the scientific evidence to support implementing couplet care has been scarce. Since moving into the new ...
Gender
ALL
Eligibility criteria
- • \[Family\]
- Inclusion Criteria:
- • Families of preterm infants born below 35 weeks of gestation at Turku University Hospital
- Exclusion Criteria:
- • The expected duration of hospitalization is less than 3 days
- • Outborn infants
- • The infants are triplets or more
- • The parents cannot understand the informed consent form in either Finnish, Swedish, English, or Russian
- • The infant's condition is critical and survival is uncertain
- • \[healthcare staff\]
- Inclusion Criteria:
- • All healthcare staff who have the possibility to participate in the decision about parent-infant early skin-to-skin contact after the delivery.
- Exclusion Criteria:
- • No
About Turku University Hospital
Turku University Hospital (TYKS) is a leading academic medical center located in Turku, Finland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a key institution within the University of Turku, TYKS integrates cutting-edge medical education with state-of-the-art clinical services, offering a broad spectrum of specialized care. The hospital actively participates in clinical trials, facilitating the translation of scientific discoveries into practical treatments, and enhancing patient outcomes. With a multidisciplinary approach and a focus on collaboration, TYKS aims to contribute significantly to the global medical community through its rigorous research initiatives and commitment to patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Liisa Lehtonen, MD
Principal Investigator
Turku University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials